Page last updated: 2024-11-07

anthglutin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

anthglutin: reversible inhibitor of glutamyl transspeptidase; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID125748
SCHEMBL ID8766412
MeSH IDM0070790

Synonyms (16)

Synonym
69168-09-8
anthglutin
gamma-glutamyl(o-carboxy)phenylhydrazide
1-gamma-l-glutamyl-2-(2-carboxyphenyl)hydrazine
ggcph
m04ovr7c8r ,
l-glutamic acid, 5-(2-(2-carboxyphenyl)hydrazide)
unii-m04ovr7c8r
2-(2-((4s)-4-amino-4-carboxybutanoyl)hydrazinyl)benzoic acid
SCHEMBL8766412
2-[2-(4-amino-4-carboxy-1-hydroxybutylidene)hydrazinyl]benzoic acid
DTXSID00988874
Q27283286
(s)-2-(2-(4-amino-4-carboxybutanoyl)hydrazinyl)benzoic acid
2-[2-[(4s)-4-amino-4-carboxybutanoyl]hydrazinyl]benzoic acid
AKOS040745565
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (84.62)18.7374
1990's2 (15.38)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]